SCHEMBL28128191

SCHEMBL28128191

Fc1cc(CN2C=Nc3ccccc3C2)ccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.39
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
DRD4 P21917 4/20 0.36
SIGMAR1 Q99720 4/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
PTGER4 P35408 1/20 0.34
DRD3 P35462 1/20 0.34
KCNH2 Q12809 1/20 0.34
CXCR3 P49682 1/20 0.34
KCNK3 O14649 1/20 0.33
P2RX7 Q99572 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28127929 0.82 HPGD (0.44) NPC1HPGDRAB9ASMN1; SMN2KDM4E
SCHEMBL28128186 0.79 ALDH1A1 (0.46) RAB9ASMN1; SMN2KDM4EALDH1A1DRD4
SCHEMBL28128217 0.75 ALDH1A1 (0.41) NPC1HPGDRAB9ASMN1; SMN2KDM4E
SCHEMBL3219206 0.75 SIGMAR1 (0.47) NPC1HPGDRAB9ASMN1; SMN2KDM4E
SCHEMBL28128161 0.74 NPC1 (0.38) NPC1HPGDRAB9ASMN1; SMN2
SCHEMBL28127948 0.74 ALDH1A1 (0.46) NPC1HPGDRAB9ASMN1; SMN2ALDH1A1
SCHEMBL28127921 0.72 TMEM97 (0.47) NPC1RAB9ASMN1; SMN2SIGMAR1KCNH2
SCHEMBL28147646 0.71 HPGD (0.50) NPC1HPGDRAB9ASMN1; SMN2ALDH1A1
SCHEMBL28228286 0.70 HPGD (0.49) NPC1HPGDRAB9ASMN1; SMN2ALDH1A1
SCHEMBL28183078 0.68 NPC1 (0.50) NPC1HPGDRAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106414430-A Pharmacologically active quinazolinedione derivatives 奥赖恩公司 2017-02-15 CN disclosed